{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:10Z","timestamp":1792182310918,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["GM125082"],"award-info":[{"award-number":["GM125082"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The widely used mood stabilizer valproate (VPA) causes perturbation of energy metabolism, which is implicated in both the therapeutic mechanism of action of the drug as well as drug toxicity. To gain insight into these mechanisms, we determined the effects of VPA on energy metabolism in yeast. VPA treatment increased levels of glycolytic intermediates, increased expression of glycolysis genes, and increased ethanol production. Increased glycolysis was likely a response to perturbation of mitochondrial function, as reflected in decreased membrane potential and oxygen consumption. Interestingly, yeast, mouse liver, and isolated bovine cytochrome\n                    <jats:italic>c<\/jats:italic>\n                    oxidase were directly inhibited by the drug, while activities of other oxidative phosphorylation complexes (III and V) were not affected. These findings have implications for mechanisms of therapeutic action and toxicity.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-68725-5","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T06:02:53Z","timestamp":1594879373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Valproate inhibits mitochondrial bioenergetics and increases glycolysis in Saccharomyces cerevisiae"],"prefix":"10.1038","volume":"10","author":[{"given":"Michael","family":"Salsaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenney","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamalagauri","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"H\u00fcttemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam L.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"68725_CR1","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1176\/appi.ajp.157.12.1925","volume":"157","author":"JM Bostwick","year":"2000","unstructured":"Bostwick, J. M. & Pankratz, V. S. Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry 157, 1925\u20131932 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"68725_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1590\/S2237-60892012000300003","volume":"34","author":"RB Mansur","year":"2012","unstructured":"Mansur, R. B. & Brietzke, E. The, \u201cselfish brain\u201d hypothesis for metabolic abnormalities in bipolar disorder and schizophrenia. Trends Psychiatry Psychother. 34, 121\u2013128 (2012).","journal-title":"Trends Psychiatry Psychother."},{"key":"68725_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jpsychores.2015.02.010","volume":"78","author":"B Silarova","year":"2015","unstructured":"Silarova, B. et al. Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls. J Psychosom. Res. 78, 391\u2013398. https:\/\/doi.org\/10.1016\/j.jpsychores.2015.02.010 (2015).","journal-title":"J Psychosom. Res."},{"key":"68725_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/mp.2014.157","volume":"20","author":"CP Johnson","year":"2015","unstructured":"Johnson, C. P. et al. Brain abnormalities in bipolar disorder detected by quantitative T1rho mapping. Mol. Psychiatry 20, 201\u2013206. https:\/\/doi.org\/10.1038\/mp.2014.157 (2015).","journal-title":"Mol. Psychiatry"},{"key":"68725_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.psyneuen.2015.02.003","volume":"55","author":"CT Li","year":"2015","unstructured":"Li, C. T. et al. Peripheral and central glucose utilizations modulated by mitochondrial DNA 10398A in bipolar disorder. Psychoneuroendocrinology 55, 72\u201380. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.02.003 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"68725_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1440-1819.2004.01197.x","volume":"58","author":"H Hamakawa","year":"2004","unstructured":"Hamakawa, H. et al. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin. Neurosci. 58, 82\u201388 (2004).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"68725_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s004060050054","volume":"248","author":"T Kato","year":"1998","unstructured":"Kato, T. et al. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity. Eur. Arch. Psychiatry Clin. Neurosci. 248, 301\u2013306 (1998).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"68725_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager, S. R. et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61, 450\u2013458. https:\/\/doi.org\/10.1001\/archpsyc.61.5.450 (2004).","journal-title":"Arch. Gen. Psychiatry"},{"key":"68725_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1017\/S003329170003347X","volume":"25","author":"T Kato","year":"1995","unstructured":"Kato, T. et al. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol. Med. 25, 557\u2013566 (1995).","journal-title":"Psychol. Med."},{"key":"68725_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(02)01911-X","volume":"53","author":"A Bertolino","year":"2003","unstructured":"Bertolino, A. et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiat. 53, 906\u2013913 (2003).","journal-title":"Biol. Psychiat."},{"key":"68725_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0006-3223(02)01744-4","volume":"53","author":"K Chang","year":"2003","unstructured":"Chang, K. et al. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol. Psychiat. 53, 1059\u20131065 (2003).","journal-title":"Biol. Psychiat."},{"key":"68725_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1176\/appi.ajp.160.5.873","volume":"160","author":"RF Deicken","year":"2003","unstructured":"Deicken, R. F., Pegues, M. P., Anzalone, S., Feiwell, R. & Soher, B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am. J. Psychiatry 160, 873\u2013882 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"68725_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.01.014","volume":"74","author":"G Morris","year":"2017","unstructured":"Morris, G. et al. A model of the mitochondrial basis of bipolar disorder. Neurosci. Biobehav. Rev. 74, 1\u201320. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.014 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"68725_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1399-5618.2008.00649.x","volume":"11","author":"O Caliyurt","year":"2009","unstructured":"Caliyurt, O. & Altiay, G. Resting energy expenditure in manic episode. Bipolar Disord. 11, 102\u2013106. https:\/\/doi.org\/10.1111\/j.1399-5618.2008.00649.x (2009).","journal-title":"Bipolar Disord."},{"key":"68725_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","volume":"42","author":"LR Baxter Jr","year":"1985","unstructured":"Baxter, L. R. Jr. et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch. Gen. Psychiatry 42, 441\u2013447 (1985).","journal-title":"Arch. Gen. Psychiatry"},{"key":"68725_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jad.2014.11.005","volume":"173","author":"U Albert","year":"2015","unstructured":"Albert, U. et al. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J. Affect. Disord. 173, 170\u2013175. https:\/\/doi.org\/10.1016\/j.jad.2014.11.005 (2015).","journal-title":"J. Affect. Disord."},{"key":"68725_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jad.2014.04.025","volume":"164","author":"SL Dubovsky","year":"2014","unstructured":"Dubovsky, S. L., Daurignac, E. & Leonard, K. E. Increased platelet intracellular calcium ion concentration is specific to bipolar disorder. J. Affect. Disord. 164, 38\u201342. https:\/\/doi.org\/10.1016\/j.jad.2014.04.025 (2014).","journal-title":"J. Affect. Disord."},{"key":"68725_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003196.pub2","author":"A Cipriani","year":"2013","unstructured":"Cipriani, A., Reid, K., Young, A. H., Macritchie, K. & Geddes, J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003196.pub2 (2013).","journal-title":"Cochrane Database Syst Rev."},{"key":"68725_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","volume":"199","author":"LV Kessing","year":"2011","unstructured":"Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M. & Andersen, P. K. Valproate v lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br. J. Psychiatry 199, 57\u201363. https:\/\/doi.org\/10.1192\/bjp.bp.110.084822 (2011).","journal-title":"Br. J. Psychiatry"},{"key":"68725_CR20","first-page":"204","volume":"230","author":"EG Brown","year":"1986","unstructured":"Brown, E. G. Sodium valproate in epilepsy treatment. Practitioner 230, 204 (1986).","journal-title":"Practitioner"},{"key":"68725_CR21","first-page":"20","volume":"101","author":"AS Petrukhin","year":"2001","unstructured":"Petrukhin, A. S. & Mukhin, K. Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety. Zh Nevrol Psikhiatr Im S S Korsakova 101, 20\u201327 (2001).","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"68725_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1526-4610.2011.02058.x","volume":"52","author":"A Blumenfeld","year":"2012","unstructured":"Blumenfeld, A., Gennings, C. & Cady, R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache 52, 636\u2013647. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.02058.x (2012).","journal-title":"Headache"},{"key":"68725_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.mp.4001518","volume":"9","author":"TD Gould","year":"2004","unstructured":"Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A. & Manji, H. K. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol. Psychiatry 9, 734\u2013755. https:\/\/doi.org\/10.1038\/sj.mp.4001518 (2004).","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 2","key":"68725_CR24","first-page":"5","volume":"37","author":"TR Henry","year":"2003","unstructured":"Henry, T. R. The history of valproate in clinical neuroscience. Psychopharmacol. Bull. 37(Suppl 2), 5\u201316 (2003).","journal-title":"Psychopharmacol. Bull."},{"key":"68725_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.1840020622","volume":"2","author":"JH Lewis","year":"1982","unstructured":"Lewis, J. H., Zimmerman, H. J., Garrett, C. T. & Rosenberg, E. Valproate-induced hepatic steatogenesis in rats. Hepatology 2, 870\u2013873 (1982).","journal-title":"Hepatology"},{"key":"68725_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","volume":"220","author":"MH Lee","year":"2007","unstructured":"Lee, M. H. et al. Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicol. Appl. Pharmacol. 220, 45\u201359. https:\/\/doi.org\/10.1016\/j.taap.2006.12.016 (2007).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"68725_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-0032-1323671","volume":"46","author":"MM Schmid","year":"2013","unstructured":"Schmid, M. M. et al. Non-fatal and fatal liver failure associated with valproic acid. Pharmacopsychiatry 46, 63\u201368. https:\/\/doi.org\/10.1055\/s-0032-1323671 (2013).","journal-title":"Pharmacopsychiatry"},{"key":"68725_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","volume":"29","author":"D Scheffner","year":"1988","unstructured":"Scheffner, D. et al. Fatal liver failure in 16 children with valproate therapy. Epilepsia 29, 530\u2013542 (1988).","journal-title":"Epilepsia"},{"key":"68725_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1528-1157.1999.tb00814.x","volume":"40","author":"SA Konig","year":"1999","unstructured":"Konig, S. A. et al. Fatal liver failure associated with valproate therapy in a patient with Friedreich\u2019s disease: review of valproate hepatotoxicity in adults. Epilepsia 40, 1036\u20131040 (1999).","journal-title":"Epilepsia"},{"key":"68725_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/aps.2013.135","volume":"35","author":"LF Zhang","year":"2014","unstructured":"Zhang, L. F. et al. Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats. Acta Pharmacol. Sin. 35, 363\u2013372. https:\/\/doi.org\/10.1038\/aps.2013.135 (2014).","journal-title":"Acta Pharmacol. Sin."},{"key":"68725_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche, K., Igoudjil, A., Pessayre, D. & Fromenty, B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6, 1\u201328. https:\/\/doi.org\/10.1016\/j.mito.2005.10.004 (2006).","journal-title":"Mitochondrion"},{"key":"68725_CR32","first-page":"133","volume":"153","author":"B Chabrol","year":"1994","unstructured":"Chabrol, B. et al. Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur. J. Pediatr. 153, 133\u2013135 (1994).","journal-title":"Eur. J. Pediatr."},{"key":"68725_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","volume":"20","author":"S Krahenbuhl","year":"2000","unstructured":"Krahenbuhl, S., Brandner, S., Kleinle, S., Liechti, S. & Straumann, D. Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20, 346\u2013348 (2000).","journal-title":"Liver"},{"key":"68725_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s004310050663","volume":"156","author":"CW Lam","year":"1997","unstructured":"Lam, C. W., Lau, C. H., Williams, J. C., Chan, Y. W. & Wong, L. J. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur. J. Pediatr. 156, 562\u2013564 (1997).","journal-title":"Eur. J. Pediatr."},{"key":"68725_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","volume":"31","author":"MF Silva","year":"2008","unstructured":"Silva, M. F. et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit. Metab. Dis. 31, 205\u2013216. https:\/\/doi.org\/10.1007\/s10545-008-0841-x (2008).","journal-title":"J. Inherit. Metab. Dis."},{"key":"68725_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"CM Becker","year":"1983","unstructured":"Becker, C. M. & Harris, R. A. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch. Biochem. Biophys. 223, 381\u2013392 (1983).","journal-title":"Arch. Biochem. Biophys."},{"key":"68725_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-C","volume":"1034","author":"M Ito","year":"1990","unstructured":"Ito, M., Ikeda, Y., Arnez, J. G., Finocchiaro, G. & Tanaka, K. The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase. Biochem. Biophys. Acta. 1034, 213\u2013218 (1990).","journal-title":"Biochem. Biophys. Acta."},{"key":"68725_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0014-5793(96)00267-0","volume":"384","author":"GS Baldwin","year":"1996","unstructured":"Baldwin, G. S., Abbott, F. S. & Nau, H. Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation. FEBS Lett. 384, 58\u201360 (1996).","journal-title":"FEBS Lett."},{"key":"68725_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0920-1211(01)00308-4","volume":"47","author":"CU Johannessen","year":"2001","unstructured":"Johannessen, C. U., Petersen, D., Fonnum, F. & Hassel, B. The acute effect of valproate on cerebral energy metabolism in mice. Epilepsy Res. 47, 247\u2013256 (2001).","journal-title":"Epilepsy Res."},{"key":"68725_CR40","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI114877","volume":"86","author":"AS Luder","year":"1990","unstructured":"Luder, A. S., Parks, J. K., Frerman, F. & Parker, W. D. Jr. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions. J. Clin. Investig. 86, 1574\u20131581. https:\/\/doi.org\/10.1172\/JCI114877 (1990).","journal-title":"J. Clin. Investig."},{"key":"68725_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.eplepsyres.2011.10.028","volume":"99","author":"M El Hage","year":"2012","unstructured":"El Hage, M., Baverel, G. & Martin, G. Effects of valproate on glutamate metabolism in rat brain slices: a (13)C NMR study. Epilepsy Res. 99, 94\u2013100. https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.10.028 (2012).","journal-title":"Epilepsy Res."},{"key":"68725_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","volume":"101","author":"Y Ohtani","year":"1982","unstructured":"Ohtani, Y., Endo, F. & Matsuda, I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J. Pediatr. 101, 782\u2013785 (1982).","journal-title":"J. Pediatr."},{"key":"68725_CR43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1345\/aph.19242","volume":"34","author":"JY Raskind","year":"2000","unstructured":"Raskind, J. Y. & El-Chaar, G. M. The role of carnitine supplementation during valproic acid therapy. Ann. Pharmacother. 34, 630\u2013638. https:\/\/doi.org\/10.1345\/aph.19242 (2000).","journal-title":"Ann. Pharmacother."},{"key":"68725_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/A:1005398516208","volume":"20","author":"MF Silva","year":"1997","unstructured":"Silva, M. F. et al. Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro. J. Inherit. Metab. Dis. 20, 397\u2013400 (1997).","journal-title":"J. Inherit. Metab. Dis."},{"key":"68725_CR45","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1016\/j.febslet.2008.08.028","volume":"582","author":"CC Aires","year":"2008","unstructured":"Aires, C. C. et al. Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes. FEBS Lett. 582, 3359\u20133366. https:\/\/doi.org\/10.1016\/j.febslet.2008.08.028 (2008).","journal-title":"FEBS Lett."},{"key":"68725_CR46","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.31.11.1473","volume":"31","author":"R Haas","year":"1981","unstructured":"Haas, R., Stumpf, D. A., Parks, J. K. & Eguren, L. Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31, 1473\u20131476 (1981).","journal-title":"Neurology"},{"key":"68725_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0022-510X(83)90174-0","volume":"61","author":"L Rumbach","year":"1983","unstructured":"Rumbach, L. et al. Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. J. Neurol. Sci. 61, 417\u2013423 (1983).","journal-title":"J. Neurol. Sci."},{"key":"68725_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2015.03.001","volume":"331","author":"T Komulainen","year":"2015","unstructured":"Komulainen, T. et al. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model. Toxicology 331, 47\u201356. https:\/\/doi.org\/10.1016\/j.tox.2015.03.001 (2015).","journal-title":"Toxicology"},{"key":"68725_CR49","doi-asserted-by":"publisher","first-page":"27460","DOI":"10.1074\/jbc.M115.683706","volume":"290","author":"RM Deranieh","year":"2015","unstructured":"Deranieh, R. M. et al. Perturbation of the Vacuolar ATPase: a novel consequence of inositol depletion. J. Biol. Chem. 290, 27460\u201327472. https:\/\/doi.org\/10.1074\/jbc.M115.683706 (2015).","journal-title":"J. Biol. Chem."},{"key":"68725_CR50","doi-asserted-by":"publisher","first-page":"22253","DOI":"10.1074\/jbc.M116.752634","volume":"291","author":"S Jadhav","year":"2016","unstructured":"Jadhav, S. et al. Valproate induces the unfolded protein response by increasing ceramide levels. J. Biol. Chem. 291, 22253\u201322261. https:\/\/doi.org\/10.1074\/jbc.M116.752634 (2016).","journal-title":"J. Biol. Chem."},{"key":"68725_CR51","doi-asserted-by":"publisher","first-page":"35322","DOI":"10.1038\/srep35322","volume":"6","author":"U Golla","year":"2016","unstructured":"Golla, U., Joseph, D. & Tomar, R. S. Combined transcriptomics and chemical-genetics reveal molecular mode of action of valproic acid, an anticancer molecule using budding yeast model. Sci. Rep. 6, 35322. https:\/\/doi.org\/10.1038\/srep35322 (2016).","journal-title":"Sci. Rep."},{"key":"68725_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.febslet.2004.12.051","volume":"579","author":"K Mitsui","year":"2005","unstructured":"Mitsui, K., Nakagawa, D., Nakamura, M., Okamoto, T. & Tsurugi, K. Valproic acid induces apoptosis dependent of Yca1p at concentrations that mildly affect the proliferation of yeast. FEBS Lett. 579, 723\u2013727. https:\/\/doi.org\/10.1016\/j.febslet.2004.12.051 (2005).","journal-title":"FEBS Lett."},{"key":"68725_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jinorgbio.2004.10.011","volume":"99","author":"M Brunori","year":"2005","unstructured":"Brunori, M., Giuffre, A. & Sarti, P. Cytochrome c oxidase, ligands and electrons. J. Inorg. Biochem. 99, 324\u2013336. https:\/\/doi.org\/10.1016\/j.jinorgbio.2004.10.011 (2005).","journal-title":"J. Inorg. Biochem."},{"key":"68725_CR54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10863-008-9181-7","volume":"40","author":"P Brzezinski","year":"2008","unstructured":"Brzezinski, P. & Gennis, R. B. Cytochrome c oxidase: exciting progress and remaining mysteries. J. Bioenergy Biomembr. 40, 521\u2013531. https:\/\/doi.org\/10.1007\/s10863-008-9181-7 (2008).","journal-title":"J. Bioenergy Biomembr."},{"key":"68725_CR55","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0006-2952(92)90590-f","volume":"43","author":"S Ponchaut","year":"1992","unstructured":"Ponchaut, S., van Hoof, F. & Veitch, K. Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem. Pharmacol. 43, 644\u2013647. https:\/\/doi.org\/10.1016\/0006-2952(92)90590-f (1992).","journal-title":"Biochem. Pharmacol."},{"key":"68725_CR56","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.bbabio.2010.08.010","volume":"568\u2013576","author":"R Diaz-Ruiz","year":"1807","unstructured":"Diaz-Ruiz, R., Rigoulet, M. & Devin, A. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochem. Biophys. Acta. 568\u2013576, 2011. https:\/\/doi.org\/10.1016\/j.bbabio.2010.08.010 (1807).","journal-title":"Biochem. Biophys. Acta."},{"key":"68725_CR57","doi-asserted-by":"publisher","first-page":"36013","DOI":"10.1038\/srep36013","volume":"6","author":"K Desfosses-Baron","year":"2016","unstructured":"Desfosses-Baron, K. et al. Valproate inhibits MAP kinase signalling and cell cycle progression in S cerevisiae. Sci. Rep. 6, 36013. https:\/\/doi.org\/10.1038\/srep36013 (2016).","journal-title":"Sci. Rep."},{"key":"68725_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00007691-200306000-00020","volume":"25","author":"M Lindberger","year":"2003","unstructured":"Lindberger, M., Tomson, T. & Stahle, L. Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humans. Ther. Drug Monit. 25, 378\u2013383 (2003).","journal-title":"Ther. Drug Monit."},{"key":"68725_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/hmg\/ddg021","volume":"12","author":"R Acin-Perez","year":"2003","unstructured":"Acin-Perez, R. et al. An intragenic suppressor in the cytochrome c oxidase I gene of mouse mitochondrial DNA. Hum. Mol. Genet 12, 329\u2013339 (2003).","journal-title":"Hum. Mol. Genet"},{"key":"68725_CR60","doi-asserted-by":"publisher","first-page":"32331","DOI":"10.1074\/jbc.M109.050146","volume":"284","author":"ME Dalmonte","year":"2009","unstructured":"Dalmonte, M. E. et al. Control of respiration by cytochrome c oxidase in intact cells: role of the membrane potential. J. Biol. Chem. 284, 32331\u201332335. https:\/\/doi.org\/10.1074\/jbc.M109.050146 (2009).","journal-title":"J. Biol. Chem."},{"key":"68725_CR61","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.mito.2010.12.004","volume":"11","author":"C Pacelli","year":"2011","unstructured":"Pacelli, C. et al. Tight control of mitochondrial membrane potential by cytochrome c oxidase. Mitochondrion 11, 334\u2013341. https:\/\/doi.org\/10.1016\/j.mito.2010.12.004 (2011).","journal-title":"Mitochondrion"},{"key":"68725_CR62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1042\/BJ20060077","volume":"396","author":"C Piccoli","year":"2006","unstructured":"Piccoli, C., Scrima, R., Boffoli, D. & Capitanio, N. Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem. J. 396, 573\u2013583. https:\/\/doi.org\/10.1042\/BJ20060077 (2006).","journal-title":"Biochem. J."},{"key":"68725_CR63","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1073\/pnas.94.4.1166","volume":"94","author":"G Villani","year":"1997","unstructured":"Villani, G. & Attardi, G. In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc. Natl. Acad. Sci. USA 94, 1166\u20131171 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68725_CR64","doi-asserted-by":"publisher","first-page":"31829","DOI":"10.1074\/jbc.273.48.31829","volume":"273","author":"G Villani","year":"1998","unstructured":"Villani, G., Greco, M., Papa, S. & Attardi, G. Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J. Biol. Chem. 273, 31829\u201331836 (1998).","journal-title":"J. Biol. Chem."},{"key":"68725_CR65","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/sj.mp.4001711","volume":"10","author":"C Stork","year":"2005","unstructured":"Stork, C. & Renshaw, P. F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10, 900\u2013919. https:\/\/doi.org\/10.1038\/sj.mp.4001711 (2005).","journal-title":"Mol. Psychiatry"},{"key":"68725_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1528-1157.1987.tb03642.x","volume":"28","author":"S Gueldry","year":"1987","unstructured":"Gueldry, S., Rochette, L. & Bralet, J. Comparison of the effects of valproate, ethosuximide, phenytoin, and pentobarbital on cerebral energy metabolism in the rat. Epilepsia 28, 160\u2013168. https:\/\/doi.org\/10.1111\/j.1528-1157.1987.tb03642.x (1987).","journal-title":"Epilepsia"},{"key":"68725_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.159.1.1","volume":"159","author":"A American Psychiatric","year":"2002","unstructured":"American Psychiatric, A. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159, 1\u201350 (2002).","journal-title":"Am. J. Psychiatry"},{"key":"68725_CR68","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/0269881109102919","volume":"23","author":"Goodwin, G. M., & Consensus Group of the British Association for P","year":"2009","unstructured":"Goodwin, G. M., & Consensus Group of the British Association for P. Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 23, 346\u2013388. https:\/\/doi.org\/10.1177\/0269881109102919 (2009).","journal-title":"J. Psychopharmacol."},{"key":"68725_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bdi.12025","volume":"15","author":"LN Yatham","year":"2013","unstructured":"Yatham, L. N. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 15, 1\u201344. https:\/\/doi.org\/10.1111\/bdi.12025 (2013).","journal-title":"Bipolar Disord."},{"key":"68725_CR70","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O","volume":"13","author":"B Gonzalez","year":"1997","unstructured":"Gonzalez, B., Francois, J. & Renaud, M. A rapid and reliable method for metabolite extraction in yeast using boiling buffered ethanol. Yeast 13, 1347\u20131355. https:\/\/doi.org\/10.1002\/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O (1997).","journal-title":"Yeast"},{"key":"68725_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-59745-365-3_6","volume":"372","author":"K Altmann","year":"2007","unstructured":"Altmann, K., Durr, M. & Westermann, B. Saccharomyces cerevisiae as a model organism to study mitochondrial biology: general considerations and basic procedures. Methods Mol. Biol. 372, 81\u201390. https:\/\/doi.org\/10.1007\/978-1-59745-365-3_6 (2007).","journal-title":"Methods Mol. Biol."},{"key":"68725_CR72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0076-6879(09)05011-3","volume":"457","author":"I Lee","year":"2009","unstructured":"Lee, I. et al. Isolation of regulatory-competent, phosphorylated cytochrome C oxidase. Methods Enzymol. 457, 193\u2013210. https:\/\/doi.org\/10.1016\/S0076-6879(09)05011-3 (2009).","journal-title":"Methods Enzymol."},{"key":"68725_CR73","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1074\/jbc.m411335200","volume":"280","author":"I Lee","year":"2005","unstructured":"Lee, I. et al. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 280, 6094\u20136100. https:\/\/doi.org\/10.1074\/jbc.m411335200 (2005).","journal-title":"J. Biol. Chem."},{"key":"68725_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.25","author":"S Magri","year":"2010","unstructured":"Magri, S., Fracasso, V., Rimoldi, M. & Taroni, F. Preparation of yeast mitochondria and in vitro assay of respiratory chain complex activities. Nat. Protoc. https:\/\/doi.org\/10.1038\/nprot.2010.25 (2010).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68725-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:41:41Z","timestamp":1670316101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68725-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68725"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68725-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11785"}}